|
Cellular Therapy & Hematologic Malignancies Grand Rounds - FY18 Five-year Results of Brentuximab Vedotin in Patients with Relapsed or Refractory Systemic Anaplastic Large Cell Lymphoma |
02/13/2018 - 8:00am to 9:00am EST |
|
Cellular Therapy & Hematologic Malignancies Grand Rounds - FY18 What We’ve Accomplished and Where We’re Going Home Transplant and PPOP |
03/13/2018 - 8:00am to 9:00am EDT |
|
Cellular Therapy & Hematologic Malignancies Grand Rounds - FY18 Depth of Response in Multiple Myeloma A Pooled Analysis of Three PETHEMA/GEM Clinical Trials Journal Club |
03/27/2018 - 8:00am EDT to 04/03/2018 - 9:00am EDT |
|
Cellular Therapy & Hematologic Malignancies Grand Rounds - FY18 Development of Clinician Scientists from the Outer Banks to the Singapore Straits |
05/08/2018 - 8:00am to 9:00am EDT |
|
Cellular Therapy & Hematologic Malignancies Grand Rounds - FY18 |
06/05/2018 - 8:00am to 9:00am EDT |
Facebook
Twitter
LinkedIn
Forward